Wanbury Ltd

About

Wanbury is engaged in the business of pharmaceutical and related activities, including research.

  • Market Cap 269 Cr.
  • Current Price 82.3
  • High / Low 115 / 32.6
  • Stock P/E
  • Book Value -47.8
  • Dividend Yield 0.00 %
  • ROCE 42.1 %
  • ROE %
  • Face Value 10.0

Pros

  • Debtor days have improved from 41.33 to 32.07 days.

Cons

  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -12.18%
  • The company has delivered a poor sales growth of -1.36% over past five years.
  • Promoter holding is low: 39.90%
  • Contingent liabilities of Rs.412.35 Cr.
  • Promoters have pledged 76.76% of their holding.
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
85.78 99.09 104.92 101.58 94.06 109.38 96.94 67.07 67.16 95.21 109.70 120.45
86.15 95.69 99.62 94.38 85.50 94.36 89.20 74.94 70.12 86.23 95.94 122.21
Operating Profit -0.37 3.40 5.30 7.20 8.56 15.02 7.74 -7.87 -2.96 8.98 13.76 -1.76
OPM % -0.43% 3.43% 5.05% 7.09% 9.10% 13.73% 7.98% -11.73% -4.41% 9.43% 12.54% -1.46%
Other Income 0.39 0.69 0.79 7.45 0.17 0.34 -0.05 83.32 0.26 0.13 0.80 1.21
Interest 6.03 5.83 5.82 22.18 7.12 7.89 7.45 10.41 6.05 5.02 6.21 5.79
Depreciation 2.53 2.52 2.49 2.43 2.46 2.46 2.40 2.37 2.37 2.40 2.39 2.59
Profit before tax -8.54 -4.26 -2.22 -9.96 -0.85 5.01 -2.16 62.67 -11.12 1.69 5.96 -8.93
Tax % 0.23% 0.47% 0.90% 0.80% 3.53% -0.40% 1.39% 0.46% -0.36% 4.73% 0.84% -0.34%
Net Profit -8.52 -4.24 -2.20 -9.89 -0.82 5.03 -2.13 62.38 -11.16 1.60 5.91 -8.95
EPS in Rs -3.59 -1.79 -0.93 -4.17 -0.35 2.12 -0.90 24.96 -4.46 0.64 2.36 -3.58

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Sep 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
472 384 386 459 661 250 420 432 370 391 367 392
459 426 388 491 637 228 387 414 438 375 344 374
Operating Profit 12 -42 -2 -32 25 21 33 19 -68 16 23 18
OPM % 3% -11% -1% -7% 4% 9% 8% 4% -18% 4% 6% 5%
Other Income 56 14 21 5 -78 6 0 90 76 9 84 2
Interest 42 47 40 37 48 19 32 36 31 40 33 23
Depreciation 16 16 17 23 23 5 9 10 10 10 10 10
Profit before tax 11 -91 -39 -87 -125 4 -7 62 -32 -25 65 -12
Tax % 21% 8% 0% -0% -2% 28% 0% 1% 1% 1% 0% -2%
Net Profit 8 -84 -39 -87 -128 3 -7 62 -32 -25 64 -13
EPS in Rs 5.73 -57.04 -22.38 -50.19 -63.95 1.60 -3.58 26.71 -13.49 -10.48 25.79 -5.04
Dividend Payout % 17% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years:0%
5 Years:-1%
3 Years:2%
TTM:7%
Compounded Profit Growth
10 Years:6%
5 Years:%
3 Years:17%
TTM:32%
Stock Price CAGR
10 Years:13%
5 Years:9%
3 Years:57%
1 Year:142%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Sep 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
15 15 17 17 20 20 20 23 24 24 25 25
Reserves 151 64 27 -65 -212 -214 -221 -176 -208 -233 -168 -181
Borrowings 469 417 455 415 389 381 362 300 250 260 190 162
166 266 309 406 209 209 227 265 207 236 232 283
Total Liabilities 801 761 809 773 406 396 388 412 273 286 279 289
441 439 439 423 174 164 180 186 178 172 164 167
CWIP 22 14 17 25 13 19 14 10 10 9 14 11
Investments 1 1 1 1 0 0 0 0 0 0 0 0
339 308 352 324 219 213 193 216 84 105 101 111
Total Assets 801 761 809 773 406 396 388 412 273 286 279 289

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Sep 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
42 137 9 87 68 40 43 43 32 30 44 17
-14 -10 -32 -21 -6 -5 -20 -13 -1 -3 64 8
-42 -129 24 -64 -71 -30 -28 -27 -33 -27 -108 -17
Net Cash Flow -15 -2 2 3 -9 5 -5 3 -2 -0 -0 7

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Sep 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Debtor Days 112 92 107 67 57 144 65 71 29 41 50 32
Inventory Days 95 96 113 63 42 103 69 63 27 36 25 42
Days Payable 149 154 159 114 113 301 172 260 174 209 253 225
Cash Conversion Cycle 57 34 61 15 -14 -55 -38 -125 -118 -131 -177 -151
Working Capital Days 133 -30 -59 -135 16 21 -9 -62 -127 -127 -146 -171
ROCE % 8% -8% -1% -11% 4% 15% 64% -1% 26% 31% 42%

Shareholding Pattern

Numbers in percentages

Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
54.93 54.93 54.93 54.93 54.93 54.93 52.13 52.13 52.09 52.09 52.09 39.90
2.26 2.26 2.26 2.26 2.26 2.28 2.14 2.14 1.36 1.13 1.13 0.01
42.81 42.81 42.81 42.81 42.81 42.79 45.73 45.73 46.56 46.78 46.78 60.09

Documents